 Terfenadine, the first non-sedating antihistamine, had to be withdrawn from the market because of the small risk of a serious side effect.However, terfenadine was discovered to be the prodrug of the active molecule, fexofenadine, which does not carry the same risks as the parent compound.Therefore, fexofenadine could be placed on the market as a safe replacement for the original drug.